4 Refining pathologic interpretation of endometrial carcinomas: lessons learned from a nationwide study in a new era of molecular classification

E Thompson, J Huvila, S Leung, J Irving, N van der Westhuizen, M Kinloch, A Lytwyn, M Sur, C Parra-Herran, A Yasmeen, F Gougeon, C Morin (+18 others)
2020 Oral Plenary   unpublished
4 Table 1 Univariable association of clinicopathologic characteristics by proactive molecular risk classifier for endometrial cancer (ProMisE) subtype Abstracts Int Conclusions MLH1/PMS2 deficient EECs exhibit more aggressive features compared to other MMRd and MMRi cases, with worse RFS. This may indicate an inherent difference in tumor biology, suggesting the importance of individualized management based on tumor's molecular phenotype. Abstract 5 Figure 1 Comparison of recurrence free
more » ... rrence free survival between mismatch repair deficient (MMRd) and mismatch repair intact (MMRi) endometrioid endometrial cancers Abstracts
doi:10.1136/ijgc-2020-igcs.4 fatcat:gne2ubessffipggiezivej5kbi